Global Key SolutionsGKS
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Janssen Pharmaceuticals, dba Actelion Pharmaceutical
FDA Inspection
•Janssen Pharmaceuticals, dba Actelion Pharmaceutical•July 21, 2011

FDA Inspection 735438 - Janssen Pharmaceuticals, dba Actelion Pharmaceutical - July 21, 2011

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Janssen Pharmaceuticals, dba Actelion Pharmaceutical, with an inspection on July 21, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Janssen Pharmaceuticals, dba Actelion Pharmaceutical
Inspection Date
July 21, 2011
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Open in Dashboard

ID · 5ce130c7-ded5-48ca-bb07-293fd0b92f28

Violation Codes1
21 CFR 314.80(b)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
[email protected]
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.